Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
FL.1.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FL.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.1.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
FL.1.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
FL.1.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
FL.1.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
FL.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.95EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.5.95EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.95ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.1.5.95ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.1.5.95EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.5.95EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.5.95ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.95ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
ET.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
ET.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
ET.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
ET.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
ET.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
ET.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
ET.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
ET.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.34EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.34EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.34ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.1.34ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.1.34EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.34EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.34ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.34ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.31EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.5.31EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.31ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.1.5.31ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.1.5.31EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.5.31EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.5.31ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.31ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.4EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.4ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.1.4ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.1.4EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.4EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.16EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.5.16EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used